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Abstract
Background
We previously derived a Universal Vital Assessment (UVA) score to better risk-stratify hospitalized patients in sub-Saharan Africa, including those with infection. Here, we aimed to
externally validate the performance of the UVA score using previously collected data from
patients hospitalized with acute infection in Rwanda.
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Methods
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We performed a secondary analysis of data collected from adults 18 years with acute
infection admitted to Gitwe District Hospital in Rwanda from 2016 until 2017. We calculated
the UVA score from the time of admission and at 72 hours after admission. We also calculated quick sepsis-related organ failure assessment (qSOFA) and modified early warning
scores (MEWS). We calculated amalgamated qSOFA scores by inserting UVA cut-offs into
the qSOFA score, and modified UVA scores by removing the HIV criterion. The performance of each score determined by the area under the receiver operator characteristic
curve (AUC) was the primary outcome measure.
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Results
We included 573 hospitalized adult patients with acute infection of whom 40 (7%) died inhospital. The admission AUCs (95% confidence interval [CI]) for the prediction of mortality
by the scores were: UVA, 0.77 (0.68–0.85); modified UVA, 0.77 (0.68–0.85); qSOFA, 0.66
(0.56–0.75), amalgamated qSOFA, 0.71 (0.61–0.80); and MEWS, 0.74 (0.64, 0.83). The
positive predictive values (95% CI) of the scores at commonly used cut-offs were: UVA >4,

PLOS ONE | https://doi.org/10.1371/journal.pone.0265713 March 23, 2022

1 / 12

PLOS ONE

Funding: The original study enrollment, the data
from which the authors performed retrospective
analyses, was funded by the Life Priority Fund, the
Hellman Foundation, and the King Baudouin
Foundation. The original research project was also
supported by the European Society of Intensive
Care Medicine and the Society of Critical Care
Medicine through the Surviving Sepsis Campaign.
The secondary analysis described in this paper was
supported by the University of Virginia Global
Infectious Diseases Institute. The funders had no
additional role in study design, data collection, and
analysis, decision to publish, or preparation of the
manuscript.

Mortality risk in hospitalized patients in Rwanda

0.35 (0.15–0.59); modified UVA >4, 0.35 (0.15–0.59); qSOFA >1, 0.14 (0.07–0.24); amalgamated qSOFA >1, 0.44 (0.20–0.70); and MEWS >5, 0.14 (0.08–0.22). The 72 hour (N =
236) AUC (95% CI) for the prediction of mortality by UVA was 0.59 (0.43–0.74). The ChiSquare test for linear trend did not identify an association between mortality and delta UVA
score at 72 hours (p = 0.82).

Conclusions
The admission UVA score and amalgamated qSOFA score had good predictive ability for
mortality in adult patients admitted to hospital with acute infection in Rwanda. The UVA
score could be used to assist with triage decisions and clinical interventions, for baseline
risk stratification in clinical studies, and in a clinical definition of sepsis in Africa.

Competing interests: The authors have declared
that no competing interests exist.

Introduction
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response
to infection and is the leading cause of mortality in low- and middle-income countries
(LMICs) [1]. Sepsis definitions have changed from being based on consensus opinion to being
based on patient derived models of increased risk of mortality due to an acute infection in
patients from high income countries (HICs) [2]. Accordingly, the Sepsis-3 operational definition of sepsis requires an increase in sepsis-related organ failure assessment (SOFA) score of 2
points from baseline. A quick SOFA (qSOFA) score was also derived to identify patients at risk
for increased mortality in the setting of infection where the components of the full SOFA score
are not available. The qSOFA score has subsequently been retrospectively evaluated in patients
from LMICs and found to provide additional information about mortality risk from baseline
data alone [3].
Other studies from sub-Saharan Africa have separately evaluated qSOFA and found that it
had variable performance depending on the population studied [4–6]. Because of the many
differences in critically ill populations in LMICs compared to those in HICs, we recently used
a large pooled dataset of hospitalized patients from 6 countries in sub-Saharan Africa to derive
and internally validate a Universal Vital Assessment (UVA) score to predict in-hospital mortality in Africa [7]. We found that the UVA score had an overall area under the receiver operating characteristic curve (AUC) of 0.77 for all hospitalized patients and 0.75 for patients with
known or suspected infection, which outperformed both qSOFA and the modified early warning score (MEWS) for all patients and in a large subset of patients with acute infection.
This finding was recently independently replicated in patients from Gabon where the UVA
score also outperformed qSOFA in the prediction of in-hospital mortality [8]. Adaptation of
the qSOFA score using UVA score cut-offs to create an amalgamated qSOFA score improved
qSOFA performance in these patients but did not in an external validation cohort from Malawi
[8]. These data suggest that different population characteristics such as HIV prevalence and
case fatality rate may influence the performance of mortality risk scores, including the UVA
score. A better understanding of a patient’s severity of illness at admission could allow for
improved risk stratification in clinical studies and inform clinical decision-making including
patient triage and allocation of resources. Therefore, the objectives of this study were to 1)
externally validate the performance of the UVA score using previously collected data from
patients hospitalized with acute infection in Rwanda; 2) determine whether changes in UVA
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score over time could predict outcomes; and 3) compare the performance of the UVA score to
those of qSOFA and MEWS.

Materials and methods
Study participants
We performed a secondary analysis of data collected from adults 18 years admitted with an
acute infectious disease to Gitwe District Hospital from the adult and pediatric Emergency
Department of Gitwe District Hospital as well as eight referring health centers in the Ruhango
District, Southern Province, Rwanda from March 2016 until March 2017 [9]. In the original
study, using a data collection tool (S1 Fig), acute infection was defined as a suspected or confirmed infection, which was based on a clinical assessment and present for less than two
weeks.

Analyses
We summarized patient characteristics as frequency with percentage for categorical variables
and median with interquartile range (IQR) for continuous variables. We used the Chi-square
test for comparisons of proportions and the Mann-Whitney U test for comparisons of continuous variables. We calculated the UVA score for each participant from the time of admission
and from 72 hours after admission. The UVA score includes points for temperature, heart
rate, respiratory rate, systolic blood pressure, oxygen saturation, GCS score, and HIV serostatus [7]. Oxygen saturation was not measured in this patient cohort. Except for sensitivity analyses in which we imputed a two for missing HIV or oxygen saturation UVA score criteria, we
did not impute missing values. We calculated the admission qSOFA score and the modified
early warning score (MEWS) for each patient [2,10]. We calculated amalgamated qSOFA
scores by inserting UVA score cut-offs for respiratory rate and systolic blood pressure into the
qSOFA score, and modified UVA scores by removing the HIV criterion from the UVA score
[8]. A comparison of the mortality risk score components and their associated point values are
found in Table 1.
We calculated the AUC for each score and compared them using the DeLong test for two
correlated receiver operator characteristic curves [11]. Using commonly used cut-offs we calculated sensitivity, specificity, positive predictive value, and negative predictive value for inhospital mortality for each score. We tested the differences between the UVA score cut-offs in
their associations with mortality using multiple logistic regressions with simultaneous tests for
general linear hypotheses, which included a statistical penalty for multiple comparisons using
Tukey contrasts. We also determined the association between the 72 hour delta UVA score (72
hour UVA score minus admission UVA score) and in-hospital mortality.

Ethical considerations
Approval for the original study and subsequent previously unplanned analyses was obtained
from the National Health and Research Committee as well as the Rwanda National Ethics
Committee (No.007/RNEC/2016). The study was conducted in accordance with ethical principles of the Declaration of Helsinki. Consent forms were translated into Kinyarwanda and written informed consent was obtained from all study participants before study enrollment. Our
secondary analysis was not included in the original study protocol. We adhered to the
Strengthening and Reporting of Observational Studies in Epidemiology (STROBE) guideline
[12].
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Table 1. A comparison of clinical mortality risk score components and their associated point values.
UVA
GCS score

SBP, mmHg

Respiratory Rate, brpm

Heart rate, bpm

Temperature,˚C

Oxygen saturation, %
HIV serostatus

Modified UVA

qSOFA

Amalgamated qSOFA

MEWS

Value

Points

Value

Points

Value

Points

Value

Points

Value

Points

15

0

15

0

15

0

15

0

A
(GCS 15)

0

<15

4

<15

4

<15

1

<15

1

V
(GCS 13)

1

---

---

---

---

---

---

---

---

P
(GCS 8)

2

---

---

---

---

---

---

---

---

U
(GCS 6)

3

90

0

90

0

>100

0

90

0

70

3

<90

1

<90

1

100

1

<90

1

71–80

2

---

---

---

---

---

---

---

---

81–100

1

---

---

---

---

---

---

---

---

101–199

0

---

---

---

---

---

---

---

---

200

2

<30

0

<30

0

<22

0

<30

0

<9

2

30

1

30

1

22

1

30

1

9–14

0

---

---

---

---

---

---

---

---

15–20

1

---

---

---

---

---

---

---

---

21–29

2

---

---

---

---

---

---

---

---

30

3

<120

0

<120

0

---

---

---

---

<40

2

120

1

120

1

---

---

---

---

41–50

1

---

---

---

---

---

---

---

---

51–100

0

---

---

---

---

---

---

---

---

101–110

1

---

---

---

---

---

---

---

---

111–129

2

---

---

---

---

---

---

---

---

130

3

36

0

36

0

---

---

---

---

<35

2

<36

2

<36

2

---

---

---

---

35–38.4

0

---

---

---

---

---

---

---

---

38.5

2

92

0

92

0

---

---

---

---

---

---

<92

2

<92

2

---

---

---

---

---

---

Positive

2

---

---

---

---

---

---

---

---

Negative/unknown

0

---

---

---

---

---

---

---

---

GCS, Glasgow coma scale; A, alert, V, verbal, P, pain, U, unresponsive; SBP, systolic blood pressure; brpm, breaths per minute; bpm, beats per minute.
https://doi.org/10.1371/journal.pone.0265713.t001

Results
We included data from 573 adult patients with known in-hospital mortality outcomes (Fig 1).
In patients with available data, 358 of 566 (63%) were women, the median (IQR) age was 38
(28–58) years and 30 of 152 (20%) with a known HIV serostatus were living with HIV
(Table 2). Death occurred in 40 of 573 (7%) patients. The admission AUCs (95% confidence
interval [CI]) for the prediction of mortality by the scores were: UVA, 0.77 (0.68–0.85); modified UVA, 0.77 (0.68–0.85); qSOFA, 0.66 (0.56–0.75), amalgamated qSOFA, 0.71 (0.61–0.80);
and MEWS, 0.74 (0.64–0.83) (Fig 2). There was a statistically significant difference between
the AUC for UVA and qSOFA (p = 0.02) but not for UVA and MEWS (p = 0.3).
In a sensitivity analysis of patients with complete data, we found that the AUCs (95% CI)
for the prediction of mortality by the scores were: UVA (n = 492), 0.77 (0.68–0.85); modified
UVA (n = 510), 0.76 (0.68–0.85); qSOFA (n = 510), 0.66 (0.57–0.76); amalgamated qSOFA
(n = 510), 0.72 (0.62–0.81); and MEWS (n = 510), 0.73 (0.64–0.83). We conducted additional
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Fig 1. Flow diagram of participant inclusion in the external validation study of the UVA score in a cohort of patients admitted to hospital
with acute infection in Gitwe, Rwanda.
https://doi.org/10.1371/journal.pone.0265713.g001

sensitivity analyses whereby we imputed a two for oxygen saturation and determined the
upper and lower UVA score AUC bounds (95% CI) as 0.77 (0.69–0.86) and 0.77 (0.69–0.86),
respectively. Similarly, we also imputed a two for HIV and established the upper and lower
UVA score AUC bounds (95% CI) as 0.77 (0.69–0.86) and 0.75 (0.65–0.85), respectively.
Increasing UVA scores were associated with increased case fatality rates and odds ratio of
death (Figs 3 and 4; Table 3). The positive predictive values (95% CI) of the scores at commonly used cut-offs were: UVA >4, 0.35 (0.15–0.59); modified UVA >4, 0.35 (0.15–0.59);
qSOFA >1, 0.14 (0.07–0.24); amalgamated qSOFA >1, 0.44 (0.20–0.70); and MEWS >5, 0.14
(0.08–0.22) (Table 4). When calculated using data obtained from patients at 72 hours
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Table 2. Population characteristics of adult patients admitted to hospital with acute infection in Gitwe, Rwanda including a comparison between those who survived hospitalization and those who died in-hospital.
Variable

Missing n (%)

Total (n = 573)

Survived (n = 533)

Died in- hospital (n = 40)

p-value

Age (years), median (IQR)

0 (0)

38 (28–58)

37 (27–56)

62 (42–72)

<0.001

Female, n (%)

7 (1)

358 (63)

343 (65)

15 (38)

0.001

421 (89)

30 (20)

26 (19)

4 (31)

0.30

Temperature (˚C), median (IQR)

13 (2)

37 (36–38)

37 (36–38)

37 (37–39)

0.27

Heart rate (bpm), median (IQR)

16 (3)

93 (80–109)

93 (79–108)

107 (87–130)

<0.001

Respiratory rate (brpm), median (IQR)

14 (2)

20 (19–20)

20 (19–20)

20 (19–22)

0.55

SBP (mmHg), median (IQR)

45 (8)

110 (97–122)

100 (98–122)

100 (84–110)

0.001

573 (100)

---

---

---

---

6 (1)

59 (10)

47 (9)

12 (30)

<0.001

Living with HIV, n (%)

Oxygen saturation, median (IQR)
GCS score <15, n (%)

Bpm, beats per minute; brpm, breaths per minute; SBP, systolic blood pressure; GCS, Glasgow coma scale.
Note that the percentages shown for the categories of total, survived, and died in-hospital are calculated from the non-missing values for each variable.
https://doi.org/10.1371/journal.pone.0265713.t002

(N = 236), the AUC (95% CI) for the prediction of mortality by UVA was 0.59 (0.43–0.74).
The Chi-Square test for linear trend did not identify an association between mortality and
delta UVA score (p = 0.82).

Discussion
In this study, we externally validated the ability of the UVA score to predict in-hospital mortality in a cohort of patients with acute infection admitted to a hospital in Rwanda who were not
part of the UVA score derivation cohort [7]. In doing so, despite a 10% difference in case fatality rates between the derivation and validation cohorts (17% vs 7%), we found that the AUC
for the prediction of in-hospital mortality was identical between derivation and validation
cohorts at 0.77 [7,9]. Increasing UVA scores were associated with increased case fatality rates
and odds ratio of death.
In a separate study from Uganda, the AUC for the UVA score was 0.82 [13]. Similar to studies in Gabon and Malawi, we found that the UVA score outperformed qSOFA [8]. We also
found that an amalgamated qSOFA score that used UVA cut-offs that were derived from a
pooled African population improved the performance of qSOFA. In our study, using a cut-off
score of >1, the amalgamated qSOFA had the highest positive predictive value (0.44) of all the
tested scores. After successful prospective validation, both the UVA score and the amalgamated qSOFA could be used clinically to identify patients at risk for in-hospital death, which
could be evaluated in a cluster randomized trial to determine whether identification of mortality risk leads to improved outcomes in different clinical settings. The UVA score has been used
by others to control for severity of illness at admission in observational clinical studies and it
could also be used for risk stratification in interventional studies [14,15]. For example, since
steroid therapy for COVID-19 is based on severity of illness, the UVA score might be a useful
indicator for steroid therapy in resource limited settings, which would need to be tested prospectively. Since the derivation of the Sepsis-3 definitions did not include any data from
patients from LMICs, the UVA score, which has consistently outperformed qSOFA in different African populations, may be useful to help determine best definitions for sepsis in Africa
[2,16].
A recent study by Klinger et al found a similar AUC for the UVA score (0.71) among
patients with suspected infection who were admitted to a tertiary hospital in Rwanda, which
was not used to conduct our study [6]. Although numerically larger, the AUC for UVA was
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Fig 2. Receiver operating characteristic curves for different mortality risk scores used to predict mortality in adult patients
admitted to hospital with acute infection in Gitwe, Rwanda.
https://doi.org/10.1371/journal.pone.0265713.g002

not statistically superior to that of qSOFA (0.65) or MEWS (0.69). However, this may be
because in the Klinger study the UVA score was calculated at the time of suspected infection,
which was frequently not at the time of admission. Accordingly, there may have been a survivor bias in the results of the Klinger study analysis of the scores as participants who died rapidly after admission to the hospital before they could be screened, or who died before infection
was suspected, were not included in the analyses. Additionally, almost half of the study population were surgical patients, a patient population that was not included in our original UVA
score derivation study. Despite these differences in study design and populations, the UVA
score maintained good performance in the Klinger study. At a cut-off of 4, the positive predictive value of the UVA score (0.41) was superior to both qSOFA (0.31) and MEWS (0.36) at
cut-offs of 2 and 4, respectively. It is possible that the calculation of the UVA score at
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Fig 3. The frequency and associated case fatality rate of UVA score risk categories (low 0–1, medium 2–4, high
>4) of adult patients admitted to hospital with acute infection in Gitwe, Rwanda.
https://doi.org/10.1371/journal.pone.0265713.g003

admission and in a more similar study population would have provided improved mortality
prediction, but this cannot be known from the available data.
Similar to the findings of the Klinger study, we also found that the UVA score calculated at
72 hours after admission performed less well than when calculated at admission. This difference in performance may be because improvement in vital signs in the short term do not necessarily predict improved outcomes in the long term due in part to immunodeficiency, poor
nutrition, and a lack of appropriate antimicrobial therapy [17–19]. For example, in a study of
the resuscitation of patients with sepsis in Uganda, we found that vital signs and whole blood
lactate improved over the first 6 hours but that these improvements were not associated with
improved case fatality rates [18]. Rather, mortality was associated with unmodifiable risk factors such as mid-upper arm circumference, a proxy for nutritional status, and low Glasgow
coma scale score, which is not typically quickly reversed in critically ill patients.
Furthermore, in a study of septic patients in Uganda, we found that increased vital sign
acquisition alone was associated with worse outcomes, perhaps reflecting increased clinical
concern for poor outcomes [17]. Therefore, the subset of patients with vital signs available at
72 hours to calculate the UVA score in the current study may have been more critically ill and
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Fig 4. Odds ratios with 95% confidence intervals for in-hospital mortality associated with medium (2–4) and high
(>4) risk UVA score categories compared to the low (0–1) risk UVA score category for adult patients admitted to
hospital with acute infection in Gitwe, Rwanda.
https://doi.org/10.1371/journal.pone.0265713.g004

not representative of outcomes for all patients at 72 hours. In another study from Uganda, we
found that 61% of deaths that occurred in patients admitted with sepsis occurred in the first 4
days of admission [19]. Therefore, the ability to survive to 72 hours may be more predictive of
subsequent survival than changes in vital signs over the first few days of admission [19]. It is
not known whether a change in UVA score, or vital signs in general, between admission and 6
to 72 hours is predictive of outcomes in this setting.
Additionally, early changes in vital sign trajectories may not predict mortality due to inappropriate antimicrobial therapy. In high HIV and tuberculosis (TB) prevalent settings such as
East Africa, including Rwanda, where in a recent study of hospitalized patients with sepsis 35%
Table 3. A multivariable analysis of the differences between the UVA cut-offs in their associations with mortality.
Odds ratio

95% confidence interval

UVA 2–4

Comparator score cut-offs
UVA 0–1

4.31

1.9–9.8

P value
0.0015

UVA >4

UVA 0–1

16.56

5.6–48.9

<0.001

UVA >4

UVA 2–4

3.84

1.3–11.7

0.046

https://doi.org/10.1371/journal.pone.0265713.t003
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Table 4. A comparison of the sensitivity, specificity, positive predictive value, and negative predictive value including 95% confidence intervals in parentheses for
in-hospital mortality for adult patients admitted to hospital with acute infection in Gitwe, Rwanda according to different cut-offs for the UVA score, Modified
UVA score, qSOFA score, Amalgamated qSOFA score, and MEWS.
Score

Sensitivity

Specificity

Positive predictive value

UVA, low risk (0–1)

0.47 (0.32–0.64)

0.19 (0.16–0.22)

0.04 (0.03–0.06)

Negative predictive value
0.83 (0.75–0.89)

UVA, medium risk (2–4)

0.35 (0.21–0.52)

0.84 (0.80–0.87)

0.14 (0.08–0.22)

0.94 (0.92–0.96)

UVA, high risk (>4)

0.17 (0.07–0.33)

0.98 (0.96–0.99)

0.35 (0.15–0.59)

0.94 (0.92–0.96)

Modified UVA, low risk (0–1)

0.53 (0.36–0.68)

0.14 (0.11–0.17)

0.04 (0.03–0.07)

0.80 (0.70–0.87)

Modified UVA, medium risk (2–4)

0.30 (0.17–0.47)

0.89 (0.86–0.91)

0.16 (0.09–0.27)

0.94 (0.92–0.96)

Modified UVA, high risk (>4)

0.17 (0.07–0.33)

0.98 (0.96–0.99)

0.35 (0.15–0.59)

0.94 (0.92–0.96)

qSOFA (>1)

0.30 (0.16–0.49)

0.87 (0.84–0.90)

0.14 (0.07–0.24)

0.95 (0.92–0.97)

Amalgamated qSOFA (>1)

0.17 (0.07–0.33)

0.98 (0.97–0.99)

0.44 (0.20–0.70)

0.94 (0.92–0.96)

MEWS (>5)

0.50 (0.32–0.68)

0.79 (0.75–0.83)

0.14 (0.08–0.22)

0.96 (0.94–0.98)

https://doi.org/10.1371/journal.pone.0265713.t004

were living with HIV, TB is the leading cause of bloodstream infections in septic patients and
is associated with high case fatality rates of approximately 20–50% [20–22]. In a pooled analysis of limited post-mortem studies of hospitalized patients from sub-Saharan Africa with HIV
and a previously unknown cause of death, the estimated prevalence of TB was 40% [23].
Among them, TB was disseminated in 88% and the cause of death in 91%. Despite the high
prevalence and burden of TB in septic patients, TB can be difficult to diagnose clinically.
Mycobacterial blood cultures are not usually available to clinicians and have a long turnaround
time. Point-of-care diagnostics such at Gene Xpert MTB/RIF and urinary lipoarabinomannan
have limited sensitivity [24]. Therefore, even if a transient improvement in UVA score, or vital
signs in general, occurs with resuscitation over 72 hours, failure to treat underlying TB or
other antimicrobial resistant pathogens would likely lead to death [19].
Our study has limitations. First, the population studied was from a single center in Rwanda
with a relatively low HIV prevalence, which may not be representative of other African settings. However, the UVA score, which was derived from pooled data from studies of hospitalized patients in 6 different countries in sub-Saharan Africa, has now been validated in separate
populations in Gabon, Uganda, and Rwanda with similar results, which provides confidence
in its generalizability across sub-Saharan Africa. Second, this was a retrospective validation
study of the UVA score and a prospective study could further determine how the UVA score
can be best deployed in different clinical settings. Third, our data were limited by the absence
of oxygen saturation data. Nonetheless, the UVA score still performed well and might be
improved with this additional information when it is available to clinicians. Similarly, the
modified UVA score without HIV status input retained good predictive ability suggesting
robustness in a real world setting where clinical data including oxygen saturation and HIV serostatus are often not available. In these cases, the amalgamated qSOFA score may offer additional predictive information. Finally, we did not have complete data at 72 hours which may
not have been missing at random due to early deaths, so our assessment of the utility of delta
UVA score at that time point was not conclusive. Further studies could evaluate whether the
delta UVA score at earlier time points provides additional predictive information regarding
mortality.

Conclusions
We found that the admission UVA score had good predictive ability for mortality in adult
patients admitted to hospital with suspected or confirmed acute infection in Rwanda. Increasing UVA scores were associated with increased case fatality rates and odds ratio of death.
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Sensitivity analyses revealed robust performance of the UVA score even when oxygen saturation and HIV serostatus were missing. The delta UVA score at 72 hours was not predictive of
mortality but this analysis was limited by a lack of available data. After successful prospective
validation, the UVA score could be used for clinical application to assist with triage decisions
and clinical interventions. It may also be used for baseline risk stratification in clinical studies
and applied to a clinical definition of sepsis in Africa.

Supporting information
S1 Fig. Data collection tool used in the original study that generated data used in the external validation of the UVA score in Rwanda study.
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